
Part 2 on coverage across payers, evidence needs for COVID-19, hepatitis B, and MMRV, and clinician messaging for maternal and newborn protection.
Vice President of the National Foundation for Infectious Diseases (NFID) and is a professor of obstetrics and gynecology at Western Michigan University Homer Stryker MD School of Medicine. He served on the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP).

Part 2 on coverage across payers, evidence needs for COVID-19, hepatitis B, and MMRV, and clinician messaging for maternal and newborn protection.

In part 1 of our conversation, the VP of the NFID discusses ACIP’s recent meeting, including COVID-19 shared decision-making, informed-consent debates, and new policy actions on hepatitis B and MMRV.

Published: September 23rd 2025 | Updated: